Welcome on Therapeutics in Dermatology !
Osler-Weber-Rendu disease or hereditary familial telangiectasia (HHT) is an inherited form of angiodysplasia of autosomal dominant transmission with variable expression. Its prevalence globally is estimated to be approximately 1 in 6000 (although prevalence is higher in some regions, such as in the department of Ain in France (1/2350) and the Danish island of Funen (1/3500) . Diagnosis is valuable because of the current potential to screen for possible complications. This means it is essential for these patients to be managed at the leading centre or in a centre with expertise in Osler-Weber-Rendu disease.
× N.B. : This limited content is for the general public. If you are a health professional, click here to register for free and gain access to a dedicated deeper content.
If you already have an account, log in!
Therapeutics in Dermatology, Fondation René Touraine © 2001-2012